Acellular Pertussis Vaccines (DTaP, Tdap)

Type: vaccine

Status: FDA Approved

Developer: Multiple pharmaceutical companies (e.g., Sanofi Pasteur, GlaxoSmithKline)

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026